Vietnam GLP-1 buyer's guide 2026: HCMC, Hanoi, Da Nang routes scored honestly

Vietnam is the supply-constrained corner of expat Southeast Asia. The Bộ Y Tế (Ministry of Health) has approved Mounjaro and Ozempic, the international expat hospitals carry them, and the prescriber side is solid. The catch is that supply runs intermittent. Even FV Hospital and Family Medical Practice — the two most reliable channels — go dry occasionally, and when they do, the supply gap can stretch to weeks. The expat playbook is to confirm stock before booking the visit.

This guide covers the four expat-routable Vietnam providers, what is actually being sold, and how to pick around the supply variance.

What is actually being sold

Three medications are in mainstream Vietnamese private prescription circulation: tirzepatide (brand Mounjaro), semaglutide (brand Ozempic, occasionally Wegovy when available), and liraglutide (brand Saxenda) at the long tail. Tirzepatide is the dominant cash-pay choice in the international hospital network. Local Vietnamese hospitals lean toward Ozempic.

What you are paying for, on a Vietnam private Rx, is some combination of:

1. The pen itself (MoH-registered import; Eli Lilly Vietnam or Novo Nordisk Vietnam) 2. A prescription from a licensed doctor at an MoH-certified facility 3. Cold-chain handling (the hospital handles this; refrigeration is rarely a question at expat-tier facilities) 4. International insurance billing or cash-pay processing

The international expat hospitals charge 2 to 3 times the local-Vietnamese hospital rate. The premium pays for English-fluent doctors, intl insurance direct billing, and supply credibility — which in Vietnam matters more than in most markets.

Per-month pricing across the market, April 2026

Vietnam GLP-1 is priced per month rather than dose-step. International hospitals use USD or accept VND with USD-equivalent reference. We pulled the public pages and intake-line numbers and normalised to a typical maintenance month at common doses.

Provider	Cities	Monthly USD	Notes

| FV Hospital | HCMC | 220 to 480 | French-Vietnamese partnership, intl insurance direct billing, expat-default. | | Family Medical Practice | HCMC, Hanoi, Da Nang | 200 to 460 | Native-English ops, transparent intake, 3 cities. | | Raffles Medical Vietnam | HCMC, Hanoi | 280 to 540 | Singapore parent gives supply credibility. | | Vinmec International | HCMC, Hanoi | 320 to 640 | Domestic premium hospital. JCI-accredited. | | Stamford Skin Centre | HCMC | 240 to 500 | Aesthetic-first framing — confirm metabolic indication. |

Numbers are accurate as of April 2026 and shift quarterly with international distribution price moves. Most providers absorb cold-chain and intake fees in the monthly figure. International insurance (Cigna, BUPA, Allianz Care) direct-bills at FV and Family Medical Practice; Raffles handles it through the Singapore parent. Vinmec accepts cash and Vietnamese insurance more readily than international.

What our 11-signal rubric scores them on

Our rubric is public. Eleven signals, each scored 0 to 100. Below is how we scored the Vietnam expat anchors.

FV Hospital — 72/100. Strongest Vietnam score in our audit. French-Vietnamese partnership, around 25 years in HCMC, intl insurance direct billing. Strong English ops, full endocrine workup at intake. Lost points on price transparency — published pricing is thin and you usually get the number at consultation rather than online. Lost more on supply continuity, where even FV runs intermittent. Routable for cohort-6 as the default expat anchor.

Family Medical Practice — 70/100. The 3-city option (HCMC, Hanoi, Da Nang). Native-English ops, the cleanest expat intake we audited in Vietnam. Lost points on supply (same intermittency as FV) and on the depth of clinical wraparound — they are a GP clinic, not a hospital, so endocrinology referrals are external. Routable, especially for users in Hanoi or Da Nang where FV does not have a presence.

We did not score Raffles Medical Vietnam in this audit round because the public pricing page is thin. The Singapore parent makes the clinical posture credible; we will revisit by Q3 2026.

We did not score Vinmec because the JCI accreditation is real but the consumer-facing operations are Vietnamese-first; the English-fluency depth is uneven across departments, and we did not have a clean cohort-6 flow to test it on.

We did not score Stamford because the aesthetic framing made the metabolic indication routing unclear in our audit. They have GLP-1 but the path to a metabolic-led consultation needs work.

Regulatory posture you should know about

Vietnam GLP-1 is overseen by the Bộ Y Tế (Vietnamese Ministry of Health) for medication registration and the Department of Health (Sở Y Tế) at the city level for clinical conduct. Mounjaro and Ozempic are MoH-registered. Wegovy distribution into Vietnam is uneven; check stock at intake.

Supply intermittency is the defining variable. Eli Lilly Vietnam and Novo Nordisk Vietnam ration distribution to MoH-certified hospitals, and the allocation cycle is monthly. When a hospital runs dry, the gap to next stock is typically 2 to 6 weeks. Expat playbook:

1. Confirm current stock at intake before booking the consultation. 2. Ask the prescriber what the typical refill cadence has been in the last 90 days — they will know. 3. If the hospital is dry, the next call is the sister international hospital in the city. FV → Family Medical Practice → Raffles is the typical waterfall. 4. Do not stockpile across the border. Vietnamese customs enforces import rules on personal pharma carry-in, and the cold-chain on a 4 to 6 hour transit from Bangkok or Singapore is real.

Vietnam has effectively no compounded GLP-1 market. Research-chemical sellers ship from China but the customs-enforcement risk and the consumer-protection asymmetry are both severe. Stay on the legal side.

If a Vietnam provider you are considering is not MoH-registered (verifiable via the licensed-facility register), do not enrol.

How to pick

The decision tree we use when matching:

You are based in HCMC and want the default expat anchor. FV Hospital. USD 220 to 480 per month, full endocrinology, the most reliable supply we have seen.

You are in Hanoi or Da Nang. Family Medical Practice. USD 200 to 460 per month, native-English ops, the only multi-city expat-tier option.

You want hospital-level depth, not GP-level. FV Hospital (HCMC) or Vinmec (HCMC, Hanoi). Vinmec is cheaper but the English-fluency is uneven; FV is the safer default if you can get there.

You want international insurance to direct-bill. FV or Family Medical Practice for Cigna, BUPA, Allianz Care. Raffles for Singapore-routed plans.

You want the cheapest legal route. Family Medical Practice at low maintenance dose. USD 200 per month is roughly the floor for expat-grade English-language service. Anything below that, ask harder questions about supply and clinical depth.

What we will not tell you is which one is "best." There is no single best; the supply variable shuffles the answer month to month. The match email Panya sends names the specific provider for your dose and budget, and confirms current supply status before routing.

What we are not covering here

Domestic Vietnamese hospitals (Cho Ray, Bach Mai, 175 Hospital). The price floor is much lower (often half or a third of international hospitals) but the English-fluency depth varies, the intake flow is built for Vietnamese-language patients, and the international insurance direct-bill is rarely available. Right answer if you are fluent in Vietnamese or have a Vietnamese-speaking partner; outside our cohort-6 routing scope.

Cross-border sourcing from Thailand or Singapore. A few expats in HCMC fly to Bangkok every 8 to 12 weeks for resupply because Thailand's cohort-1 vendors are more consistent. We do not route here because the cold-chain risk on the transit is real and the resupply cadence is fragile if the next flight is cancelled.

Telehealth-only flows. Vietnam does not currently have a meaningful telehealth GLP-1 market. The hospitals run hybrid (intake in person, follow-up via WhatsApp or Zalo) but pure-online prescription is not standard.

Sources we audited against

• Bộ Y Tế registration database, April 2026
• Each provider's published pricing and intake page (April 2026)
• Cohort-6 outreach research, internal
• WHO 2026 expat health-services Southeast Asia review
• International insurance direct-bill verification (Cigna, BUPA, Allianz Care)

Updated April 2026. We refresh quarterly. Last updated 2026-04-26.

If you spot a number that has shifted or a provider we have miscategorised, email partner@panya.health and we will check the source and update the page with a public changelog.